Use of platelet rich plasma(PRP) as an adjunct in the treatment of high peri-anal fistulas.

Use of platelet rich plasma(PRP) as an adjunct in the treatment of high peri-anal fistulas. - -

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON43622

Enrollment

120

Registered

2012-03-12

Start date

2012-04-26

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fistula

Interventions

Intervention: injection of PRP at the curreted fistula track under the mucosal flap.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: no bias to sex, age 16-80 years, able to understand informed consent, high peri-anal fistula

Exclusion criteria

Exclusion criteria: -inability to fullfill follow-up criteria -pregnant -local malignancy -Crohn*s disease/Ulcerative colitis -patients with a traumatic/iatrogenic lesion -Trombocytopenia - Splenomegaly

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoint primary: recurrence rate	—

Secondary

Measure	Time frame
Main study parameters/endpoints secundary: post-operative pain, continence, quality of life.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)